LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 95 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,913,675 | -58.1% | 8,784,813 | -9.4% | 7.17% | -52.7% |
| Q2 2023 | $30,846,000 | +30.7% | 9,700,000 | -3.0% | 15.16% | +23.8% |
| Q1 2023 | $23,600,000 | -32.0% | 10,000,000 | 0.0% | 12.24% | -17.4% |
| Q4 2022 | $34,700,000 | -52.7% | 10,000,000 | 0.0% | 14.82% | -37.1% |
| Q3 2022 | $73,300,000 | -15.4% | 10,000,000 | -24.7% | 23.57% | +1.1% |
| Q2 2022 | $86,600,000 | +29.1% | 13,282,181 | 0.0% | 23.32% | +24.3% |
| Q1 2022 | $67,075,000 | -34.8% | 13,282,181 | 0.0% | 18.76% | -11.3% |
| Q4 2021 | $102,804,000 | -47.7% | 13,282,181 | 0.0% | 21.15% | -26.9% |
| Q3 2021 | $196,576,000 | -8.9% | 13,282,181 | 0.0% | 28.95% | -0.7% |
| Q2 2021 | $215,703,000 | – | 13,282,181 | – | 29.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $29,638,628 | 28.72% |
| Orland Properties Ltd | 15,093,969 | $22,188,134 | 11.75% |
| Foresite Capital Management IV, LLC | 8,784,813 | $12,913,675 | 7.17% |
| MIC Capital Management UK LLP | 1,740,569 | $2,558,636 | 0.58% |
| Alphabet Inc. | 5,865,125 | $8,621,733 | 0.55% |
| HSG Holding Ltd | 3,045,997 | $4,477,616 | 0.48% |
| Clarius Group, LLC | 399,168 | $586,777 | 0.06% |
| CAXTON ASSOCIATES LP | 198,477 | $291,761 | 0.04% |
| XTX Topco Ltd | 114,720 | $168,638 | 0.03% |
| BBR PARTNERS, LLC | 164,041 | $241,140 | 0.03% |